These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14305953)

  • 1. [SERO-PROTECTION OF THE CHICK EMBRYO AGAINST SALMONELLA PARATYPHI A INFECTION. APPLICATION OF THE ASSAY OF VACCINES].
    VLADOIANU IR; DIMACHE G; POPESCO P; MEREUTA H; LOWE I; DINCOLESCO M; DIMACHE V
    Ann Inst Pasteur (Paris); 1965 Feb; 108():246-54. PubMed ID: 14305953
    [No Abstract]   [Full Text] [Related]  

  • 2. [Test of virulence of Salmonella paratyphi A on chick embryo: its use in serological protection of subjects immunized by anti-typho-paratyphoid vaccine].
    GRABAR J; LE MINOR S
    Ann Inst Pasteur (Paris); 1956 Jul; 91(1):117-20. PubMed ID: 13340341
    [No Abstract]   [Full Text] [Related]  

  • 3. [The anti-Salmonella paratyphi B vaccination].
    Dimache G; Vlădoianu IR; Dimache V; Popescu P; Antonescu O; Mitrea D
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):477-86. PubMed ID: 4999244
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental research concerning the virulence and immunogenic capacity of S. paratyphi C and S. cholerae suis].
    Nestoresco N; Popovici M; Vlădoianu IR; Dincoulesco M; Dimache G; Dimache V
    Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):363-72. PubMed ID: 5877476
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
    Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
    Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of paratyphoid fever vaccine research and development.
    Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
    Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory-based surveillance of paratyphoid fever in the United States: travel and antimicrobial resistance.
    Gupta SK; Medalla F; Omondi MW; Whichard JM; Fields PI; Gerner-Smidt P; Patel NJ; Cooper KL; Chiller TM; Mintz ED
    Clin Infect Dis; 2008 Jun; 46(11):1656-63. PubMed ID: 18422453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
    Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
    Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SALMONELLOSIS IN CANADA-1953 TO 1963.
    YURACK JA; BEST EW
    Med Serv J Can; 1964 Jun; 20():519-26. PubMed ID: 14181725
    [No Abstract]   [Full Text] [Related]  

  • 12. EFFECT OF AN ANTIBIOTIC REGIME ON MONKEYS EXPOSED TO TOTAL-BODY IRRADIATION.
    BYRON JW; HAIGH MV; LAJTHA LG
    Nature; 1964 Jun; 202():977-9. PubMed ID: 14197331
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chick-embryo sero-protection test for evaluation of efficacy of the oral immunization by inactivated T.A.B. vaccine].
    Dimache G
    Ann Sclavo; 1972; 14(5):599-610. PubMed ID: 4669414
    [No Abstract]   [Full Text] [Related]  

  • 14. [RESEARCH ON THE EFFECTIVENESS OF INCUBATION AT 43 DEGREES OF ENRICHMENT MEDIA FOR THE ISOLATION OF SALMONELLA].
    IVANOV A; STRUSIEVICI B; LENGHEL I
    Microbiol Parazitol Epidemiol (Bucur); 1963; 8():61-8. PubMed ID: 14047909
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacteriological and serological findings in Salmonella paratyphi infection.
    RODA AP; AVIADO-TANQUINTIC Z; JIMENEZ M
    J Philipp Med Assoc; 1951 Jan; 27(1):7-20. PubMed ID: 14825104
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
    Hatunceva NV; Mironova MV; Ryapolova RG
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteriologic studies in an outbreak of salmonellosis in Korea, with special attention to Salmonella paratyphi and perforations of paratyphoid ulcers.
    ZIMMERMAN LE; COOPER M; GRABER CD
    Am J Hyg; 1952 Nov; 56(3):252-64. PubMed ID: 12996494
    [No Abstract]   [Full Text] [Related]  

  • 19. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
    Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL
    Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology of Salmonella infections].
    Bonard EC
    Rev Med Suisse Romande; 1974 Apr; 94(4):271-88. PubMed ID: 4207839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.